1
|
Svitek N, Saya R, Zhang H, Nene V, Steinaa L. Systematic Determination of TCR–Antigen and Peptide–MHC Binding Kinetics among Field Variants of a Theileria parva Polymorphic CTL Epitope. THE JOURNAL OF IMMUNOLOGY 2022; 208:549-561. [PMID: 35031580 PMCID: PMC8802549 DOI: 10.4049/jimmunol.2100400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Accepted: 11/23/2021] [Indexed: 11/24/2022]
Abstract
Positions 1–3 in the Tp9 CTL epitope are required for binding to BoLA-1*023:01. Positions 5–8 in the Tp9 epitope are required for TCR recognition in diverse CTLs. Tp9-specific CTLs from Muguga-immunized animals can cross-react with variants 4 and 7.
CTLs are known to contribute to immunity toward Theileria parva, the causative agent of East Coast fever. The Tp967–75 CTL epitope from the Muguga strain of T. parva is polymorphic in other parasite strains. Identifying the amino acids important for MHC class I binding, as well as TCR recognition of epitopes, can allow the strategic selection of Ags to induce cellular immunity toward T. parva. In this study, we characterized the amino acids important for MHC class I binding and TCR recognition in the Tp967–75 epitope using alanine scanning and a series of variant peptide sequences to probe these interactions. In a peptide–MHC class I binding assay, we found that the amino acids at positions 1, 2, and 3 were critical for binding to its restricting MHC class I molecule BoLA-1*023:01. With IFN-γ ELISPOT and peptide–MHC class I Tet staining assays on two parasite-specific bovine CTL lines, we showed that amino acids at positions 5–8 in the epitope were required for TCR recognition. Only two of eight naturally occurring polymorphic Tp9 epitopes were recognized by both CTLs. Finally, using a TCR avidity assay, we found that a higher TCR avidity was associated with a stronger functional response toward one of two variants recognized by the CTL. These data add to the growing knowledge on the cross-reactivity of epitope-specific CTLs and specificities that may be required in the selection of Ags in the design of a wide-spectrum vaccine for East Coast fever.
Collapse
Affiliation(s)
- Nicholas Svitek
- International Livestock Research Institute, Animal and Human Health Program, Nairobi, Kenya; and
| | - Rosemary Saya
- International Livestock Research Institute, Animal and Human Health Program, Nairobi, Kenya; and
| | - Houshuang Zhang
- Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Minhang District, Shanghai, China
| | - Vishvanath Nene
- International Livestock Research Institute, Animal and Human Health Program, Nairobi, Kenya; and
| | - Lucilla Steinaa
- International Livestock Research Institute, Animal and Human Health Program, Nairobi, Kenya; and
| |
Collapse
|
2
|
Allan FK, Peters AR. Safety and Efficacy of the East Coast Fever Muguga Cocktail Vaccine: A Systematic Review. Vaccines (Basel) 2021; 9:vaccines9111318. [PMID: 34835249 PMCID: PMC8623010 DOI: 10.3390/vaccines9111318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Revised: 10/27/2021] [Accepted: 10/29/2021] [Indexed: 12/04/2022] Open
Abstract
Immunisation of livestock with high quality vaccines is considered an essential approach to controlling many animal diseases. The only currently available commercial vaccine to protect cattle from East Coast fever (ECF), a tick-borne disease caused by Theileria parva, is an unconventional “infection and treatment method” (ITM) involving administration of a combination of live T. parva isolates, referred to as the “Muguga cocktail”, and simultaneous treatment with long-acting oxytetracycline. Veterinary vaccine research and development typically involves studies designed to demonstrate vaccine quality, safety, and efficacy; however, as there were no such purpose-designed registration studies conducted for the Muguga cocktail, evidence for safety and efficacy is solely based on that which is available in the clinical literature. An extensive systematic review was conducted to analyse the evidence available in the literature in order to establish the safety and efficacy of the Muguga cocktail vaccine. A combination of meta-analyses and narrative summaries was conducted. A total of 61 studies met the criteria to be included in the systematic review. The majority of studies demonstrated or reported in favour of the vaccine with regards to safety and efficacy of the Muguga cocktail vaccine. Proximity to buffalo often resulted in reduced vaccine efficacy, and reports of shed and transmission of vaccine components affected the overall interpretation of safety. Better understanding of control options for this devastating livestock disease is important for policymakers and livestock keepers, enabling them to make informed decisions with regards to the health of their animals and their livelihoods.
Collapse
|
3
|
Lubembe DM, Odongo DO, Joubert F, Sibeko-Matjila KP. Limited diversity in the CD8+ antigen-coding loci in Theileria parva parasites from cattle from southern and eastern Africa. Vet Parasitol 2021; 291:109371. [PMID: 33621717 DOI: 10.1016/j.vetpar.2021.109371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2020] [Accepted: 01/23/2021] [Indexed: 11/17/2022]
Abstract
Theileria parva infections in cattle causes huge economic losses in the affected African countries, directly impacting the livelihood of the poor small-holder farmers. The current immunization protocol using live sporozoites in eastern Africa, is among the control measures designed to limit T. parva infections in cattle. However, the ability of the immune protection induced by this immunization to protect against field parasites has been compromised by the diversity of the parasite involving the schizont antigen genes. Previous studies have reported on the antigenic diversity of T. parva parasites from southern and eastern Africa, however, similar reports on T. parva parasites particularly from cattle from southern Africa remains scanty, due to the self-limiting nature of Corridor disease. Thus, we evaluated the diversity of CD8+ T-cell regions of ten schizont antigen genes in T. parva parasites associated with Corridor disease and East Coast fever (ECF) from southern and eastern Africa respectively. Regions of schizont antigen (TpAg) genes containing the CD8+ T-cell epitopes (CTL determinants) were amplified from genomic DNA extracted from blood of T. parva positive samples, cloned and sequenced. The results revealed limited diversity between the two parasite groups from cattle from southern and eastern Africa, defying the widely accepted notion that antigen-encoding loci in cattle-derived parasites are conserved, while in buffalo-derived parasites, they are extensively variable. This suggests that only a sub-population of parasites is successfully transmitted from buffalo to cattle, resulting in the limited antigenic diversity in Corridor disease parasites. Tp4, Tp5, Tp7 and Tp8 showed limited to absence of diversity in both parasite groups, suggesting the need to further investigate their immunogenic properties for consideration as candidates for a subunit vaccine. Distinct and common variants of Tp2 were detected among the ECF parasites from eastern Africa indicating evidence of parasite mixing following immunization. This study provides additional information on the comparative diversity of TpAg genes in buffalo- and cattle-derived T. parva parasites from cattle from southern and eastern Africa.
Collapse
Affiliation(s)
- Donald M Lubembe
- Vectors and Vector-borne Diseases Research Programme, Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort, South Africa.
| | - David O Odongo
- School of Biological Sciences, University of Nairobi, P.O. Box 30197, Nairobi, 00100, Kenya
| | - Fourie Joubert
- Centre for Bioinformatics and Computational Biology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Private Bag X20, Hatfield, South Africa
| | - Kgomotso P Sibeko-Matjila
- Vectors and Vector-borne Diseases Research Programme, Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort, South Africa
| |
Collapse
|
4
|
Amzati GS, Djikeng A, Odongo DO, Nimpaye H, Sibeko KP, Muhigwa JBB, Madder M, Kirschvink N, Marcotty T. Genetic and antigenic variation of the bovine tick-borne pathogen Theileria parva in the Great Lakes region of Central Africa. Parasit Vectors 2019; 12:588. [PMID: 31842995 PMCID: PMC6915983 DOI: 10.1186/s13071-019-3848-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 12/10/2019] [Indexed: 02/07/2023] Open
Abstract
Background Theileria parva causes East Coast fever (ECF), one of the most economically important tick-borne diseases of cattle in sub-Saharan Africa. A live immunisation approach using the infection and treatment method (ITM) provides a strong long-term strain-restricted immunity. However, it typically induces a tick-transmissible carrier state in cattle and may lead to spread of antigenically distinct parasites. Thus, understanding the genetic composition of T. parva is needed prior to the use of the ITM vaccine in new areas. This study examined the sequence diversity and the evolutionary and biogeographical dynamics of T. parva within the African Great Lakes region to better understand the epidemiology of ECF and to assure vaccine safety. Genetic analyses were performed using sequences of two antigen-coding genes, Tp1 and Tp2, generated among 119 T. parva samples collected from cattle in four agro-ecological zones of DRC and Burundi. Results The results provided evidence of nucleotide and amino acid polymorphisms in both antigens, resulting in 11 and 10 distinct nucleotide alleles, that predicted 6 and 9 protein variants in Tp1 and Tp2, respectively. Theileria parva samples showed high variation within populations and a moderate biogeographical sub-structuring due to the widespread major genotypes. The diversity was greater in samples from lowlands and midlands areas compared to those from highlands and other African countries. The evolutionary dynamics modelling revealed a signal of selective evolution which was not preferentially detected within the epitope-coding regions, suggesting that the observed polymorphism could be more related to gene flow rather than recent host immune-based selection. Most alleles isolated in the Great Lakes region were closely related to the components of the trivalent Muguga vaccine. Conclusions Our findings suggest that the extensive sequence diversity of T. parva and its biogeographical distribution mainly depend on host migration and agro-ecological conditions driving tick population dynamics. Such patterns are likely to contribute to the epidemic and unstable endemic situations of ECF in the region. However, the fact that ubiquitous alleles are genetically similar to the components of the Muguga vaccine together with the limited geographical clustering may justify testing the existing trivalent vaccine for cross-immunity in the region.
Collapse
Affiliation(s)
- Gaston S Amzati
- Research Unit of Veterinary Epidemiology and Biostatistics, Faculty of Agricultural and Environmental Sciences, Université Evangélique en Afrique, PO Box 3323, Bukavu, Democratic Republic of the Congo. .,Unit of Integrated Veterinary Research, Department of Veterinary Medicine, Faculty of Sciences, Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Rue de Bruxelles 61, 5000, Namur, Belgium. .,Biosciences Eastern and Central Africa - International Livestock Research Institute (BecA-ILRI) Hub, PO Box 30709-00100, Nairobi, Kenya.
| | - Appolinaire Djikeng
- Biosciences Eastern and Central Africa - International Livestock Research Institute (BecA-ILRI) Hub, PO Box 30709-00100, Nairobi, Kenya.,Centre for Tropical Livestock Genetics and Health (CTLGH), The University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, Scotland, UK
| | - David O Odongo
- Biosciences Eastern and Central Africa - International Livestock Research Institute (BecA-ILRI) Hub, PO Box 30709-00100, Nairobi, Kenya.,School of Biological Sciences, University of Nairobi, PO Box 30197-00100, Nairobi, Kenya
| | - Herman Nimpaye
- Faculty of Medicine, University of Burundi, PO Box 1550, Bujumbura, Burundi
| | - Kgomotso P Sibeko
- Vector and Vector-Borne Disease Research Programme, Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, P/Bag X04, Onderstepoort, Gauteng, 0110, South Africa
| | - Jean-Berckmans B Muhigwa
- Research Unit of Veterinary Epidemiology and Biostatistics, Faculty of Agricultural and Environmental Sciences, Université Evangélique en Afrique, PO Box 3323, Bukavu, Democratic Republic of the Congo
| | - Maxime Madder
- Vector and Vector-Borne Disease Research Programme, Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, P/Bag X04, Onderstepoort, Gauteng, 0110, South Africa
| | - Nathalie Kirschvink
- Unit of Integrated Veterinary Research, Department of Veterinary Medicine, Faculty of Sciences, Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Rue de Bruxelles 61, 5000, Namur, Belgium
| | - Tanguy Marcotty
- Unit of Integrated Veterinary Research, Department of Veterinary Medicine, Faculty of Sciences, Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Rue de Bruxelles 61, 5000, Namur, Belgium
| |
Collapse
|